Skip to main content

Medexus Pharmaceuticals Inc(MDP-T)
TSX

Today's Change
Real-Time Last Update
Volume

Latest News

Medexus Pharma: Bottom 25 Performing Stocks Year-to-Date on TSX (MDP)
The Globe and Mail - Thu Nov 10, 10:04AM CST
The Globe and Mail
Thu Nov 10, 10:04AM CST
Medexus Pharma is among the group of bottom performing stocks year-to-date on the Toronto Stock Exchange. This means each stock on this list has seen its share price decrease at a faster rate than the rest of the market so far this year.
Medexus Pharma: Bottom 25 Performing Stocks Year-to-Date on TSX (MDP)
The Globe and Mail - Thu Oct 13, 7:04AM CDT
The Globe and Mail
Thu Oct 13, 7:04AM CDT
Medexus Pharma is among the group of bottom performing stocks year-to-date on the Toronto Stock Exchange. This means each stock on this list has seen its share price decrease at a faster rate than the rest of the market so far this year.
Stocks in play: Medexus Pharmaceuticals
Baystreet - Thu Oct 6, 9:10AM CDT
Baystreet
Thu Oct 6, 9:10AM CDT
Announced preliminary estimates of the company’s revenue results for the fiscal quarter ended September ...
Medexus Pharma: Top 10 Undervalued Drug Manufacturers Industry Stocks (MDP)
The Globe and Mail - Sun Oct 2, 7:05AM CDT
The Globe and Mail
Sun Oct 2, 7:05AM CDT
Medexus Pharma is now ranked among the top 10 undervalued stocks in the Drug Manufacturers industry on the Toronto Stock Exchange or TSX Venture Exchange. A stock is considered undervalued if it trades at a discount to its valuation – a...
Medexus Pharma: Top 10 Undervalued Healthcare Stocks on TSE (MDP)
The Globe and Mail - Tue Sep 20, 11:54AM CDT
The Globe and Mail
Tue Sep 20, 11:54AM CDT
Medexus Pharma is now ranked among the top 10 undervalued stocks in the Healthcare sector on the Toronto Stock Exchange. A stock is considered undervalued if it trades at a discount to its valuation – a calculation used to determine the intrinsic...
Medexus Pharma: Bottom 25 Performing Stocks Year-to-Date on TSE (MDP)
The Globe and Mail - Thu Sep 15, 11:53AM CDT
The Globe and Mail
Thu Sep 15, 11:53AM CDT
Medexus Pharma is among the group of bottom performing stocks year-to-date on the Toronto Stock Exchange. This means each stock on this list has seen its share price decrease at a faster rate than the rest of the market so far this year.
Medexus Pharma: Bottom 25 Performing Stocks Year-to-Date on Toronto Stock Exchange (MDP)
The Globe and Mail - Thu Aug 18, 9:02AM CDT
The Globe and Mail
Thu Aug 18, 9:02AM CDT
Medexus Pharma is among the group of bottom performing stocks year-to-date on the Toronto Stock Exchange. This means each stock on this list has seen its share price decrease at a faster rate than the rest of the market so far this year.
Medexus Announces Record Fiscal Q1 2023 Revenue of US$23.0 Million, a 33% Increase versus Fiscal Q1 2022
Globe Newswire - Mon Aug 8, 4:00PM CDT
Globe Newswire
Mon Aug 8, 4:00PM CDT
Results include first U.S. revenue from Gleolan, full commercial launch expected in fiscal Q2 Treosulfan NDA resubmitted to the FDA, regulatory...
Medexus Pharma MDP is in the bottom 25 performing stocks year-to-date on the Toronto Stock Exchange
The Globe and Mail - Thu Aug 4, 9:02AM CDT
The Globe and Mail
Thu Aug 4, 9:02AM CDT
Medexus Pharma is among the group of bottom performing stocks year-to-date on the Toronto Stock Exchange. This means each stock on this list has seen its share price grow at a faster rate than the rest of the market so far this year.
Medexus Pharma MDP is in the bottom 25 performing stocks year-to-date on the Toronto Stock Exchange
The Globe and Mail - Tue Aug 2, 7:00PM CDT
The Globe and Mail
Tue Aug 2, 7:00PM CDT
Medexus Pharma is among the group of bottom performing stocks year-to-date on the Toronto Stock Exchange. This means each stock on this list has seen its share price grow at a faster rate than the rest of the market so far this year.